NDRA logo

ENDRA Life Sciences (NDRA) Cash From Operations

Annual CFO

-$9.55 M
+$3.22 M+25.22%

December 31, 2023

Summary

Performance

1-Year Change

+25.22%

3-Year Change

+11.15%

5-Year Change

-23.97%

15-Year Change

-189.28%

NDRA Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

61.26%
NDRA annual cash flow from operations is higher than 61.26% of companies in Healthcare sector

High & Low

All-time High

-$842.70 K

3-Year Low

-$12.77 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
NDRA previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 28, 2025
NDRA next annual earnings announcement is scheduled for Mar 28, 2025

OtherNDRAcash flowmetrics:

Annual CFI

-$24.70 K
NDRA annual cash flow from investing activities is -$24.70 thousand

Annual CFF

$7.52 M
NDRA annual cash flow from financing activities is $7.52 million

Annual FCF

-$9.58 M
NDRA annual free cash flow is -$9.58 million

Annual CAPEX

-
NDRA annual capital expenditures value is unknown

Quarterly CFO

-$1.66 M
+$426.10 K+20.45%

September 30, 2024

Summary

Performance

3-Month Change

+20.45%

1-Year Change

+36.23%

3-Year Change

+36.23%

5-Year Change

+36.23%

NDRA Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

63.13%
NDRA quarterly cash flow from operations is higher than 63.13% of companies in Healthcare sector

High & Low

All-time High

$0.00
NDRA quarterly cash flow from operations is currently <-9900.00% below its historical high of $0.00

3-Year Low

-$3.33 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
NDRA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
NDRA next earnings announcement is scheduled for Mar 28, 2025

OtherNDRAcash flowmetrics:

Quarterly CFI

$0.00
NDRA quarterly cash flow from investing activities is $0.00

Quarterly CFF

$1700.00
NDRA quarterly cash flow from financing activities is $1700.00

Quarterly FCF

-$1.66 M
NDRA quarterly free cash flow is -$1.66 million

Quarterly CAPEX

-
NDRA quarterly capital expenditures value is unknown

TTM CFO

-$8.06 M
+$941.60 K+10.46%

September 30, 2024

Summary

Performance

3-Month Change

+10.46%

1-Year Change

+22.97%

3-Year Change

+22.97%

5-Year Change

+22.97%

NDRA TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

62.61%
NDRA TTM cash flow from operations is higher than 62.61% of companies in Healthcare sector

High & Low

All-time High

-$53.80 K

3-Year Low

-$12.77 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
NDRA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
NDRA next earnings announcement is scheduled for Mar 28, 2025

OtherNDRAcash flowmetrics:

TTM CFI

-$10.50 K
NDRA TTM cash flow from investing activities is -$10.50 thousand

TTM CFF

$9.48 M
NDRA TTM cash flow from financing activities is $9.48 million

TTM FCF

-$8.08 M
NDRA TTM free cash flow is -$8.08 million

TTM CAPEX

-
NDRA TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

NDRA Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+25.2%+36.2%+23.0%
3 y3 years+11.2%+36.2%+23.0%
5 y5 years-24.0%+36.2%+23.0%

NDRA Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+25.2%at high+50.3%at high+36.9%
5 y5-year-11.2%+25.2%at high+52.0%at high+36.9%
alltimeall time-1033.1%+25.2%<-9999.0%+52.0%<-9999.0%+36.9%

ENDRA Life Sciences Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.66 M(-20.5%)
-$8.06 M(-10.5%)
Jun 2024
-
-$2.08 M(-2.8%)
-$9.00 M(-2.0%)
Mar 2024
-
-$2.14 M(-1.4%)
-$9.19 M(-3.8%)
Dec 2023
-$9.55 M(-25.2%)
-$2.17 M(-16.3%)
-$9.55 M(-8.7%)
Sep 2023
-
-$2.60 M(+14.6%)
-$10.46 M(-5.8%)
Jun 2023
-
-$2.27 M(-9.5%)
-$11.11 M(-8.8%)
Mar 2023
-
-$2.51 M(-18.8%)
-$12.18 M(-4.6%)
Dec 2022
-$12.77 M(+14.8%)
-$3.09 M(-4.9%)
-$12.77 M(+3.5%)
Sep 2022
-
-$3.25 M(-2.6%)
-$12.33 M(+4.2%)
Jun 2022
-
-$3.33 M(+7.6%)
-$11.83 M(+4.7%)
Mar 2022
-
-$3.10 M(+16.8%)
-$11.30 M(+1.6%)
Dec 2021
-$11.12 M(+3.5%)
-$2.65 M(-3.4%)
-$11.12 M(+5.5%)
Sep 2021
-
-$2.75 M(-1.9%)
-$10.54 M(+6.2%)
Jun 2021
-
-$2.80 M(-4.2%)
-$9.93 M(-6.2%)
Mar 2021
-
-$2.92 M(+41.0%)
-$10.58 M(-1.5%)
Dec 2020
-$10.75 M
-$2.07 M(-2.8%)
-$10.75 M(+1.6%)
Sep 2020
-
-$2.13 M(-38.2%)
-$10.58 M(-3.2%)
Jun 2020
-
-$3.45 M(+11.8%)
-$10.93 M(+19.6%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$3.09 M(+61.9%)
-$9.14 M(+6.4%)
Dec 2019
-$8.59 M(+11.5%)
-$1.91 M(-23.2%)
-$8.59 M(+0.1%)
Sep 2019
-
-$2.48 M(+49.7%)
-$8.58 M(+13.4%)
Jun 2019
-
-$1.66 M(-34.7%)
-$7.57 M(-2.8%)
Mar 2019
-
-$2.54 M(+33.6%)
-$7.79 M(+1.2%)
Dec 2018
-$7.70 M(+133.3%)
-$1.90 M(+29.5%)
-$7.70 M(+7.3%)
Sep 2018
-
-$1.47 M(-21.9%)
-$7.18 M(+14.7%)
Jun 2018
-
-$1.88 M(-23.3%)
-$6.25 M(+13.4%)
Mar 2018
-
-$2.45 M(+78.2%)
-$5.52 M(+67.1%)
Dec 2017
-$3.30 M(+150.9%)
-$1.38 M(+151.7%)
-$3.30 M(+33.6%)
Sep 2017
-
-$546.60 K(-52.2%)
-$2.47 M(+28.4%)
Jun 2017
-
-$1.14 M(+383.5%)
-$1.92 M(+28.5%)
Mar 2017
-
-$236.30 K(-56.7%)
-$1.50 M(+13.9%)
Dec 2016
-$1.32 M(+56.1%)
-$546.20 K(<-9900.0%)
-$1.32 M(+71.0%)
Sep 2016
-
$0.00(-100.0%)
-$769.50 K(0.0%)
Jun 2016
-
-$715.70 K(+1230.3%)
-$769.50 K(+1330.3%)
Mar 2016
-
-$53.80 K
-$53.80 K
Dec 2015
-$842.70 K(-39.7%)
-
-
Dec 2014
-$1.40 M
-
-

FAQ

  • What is ENDRA Life Sciences annual cash flow from operations?
  • What is the all time high annual CFO for ENDRA Life Sciences?
  • What is ENDRA Life Sciences annual CFO year-on-year change?
  • What is ENDRA Life Sciences quarterly cash flow from operations?
  • What is the all time high quarterly CFO for ENDRA Life Sciences?
  • What is ENDRA Life Sciences quarterly CFO year-on-year change?
  • What is ENDRA Life Sciences TTM cash flow from operations?
  • What is the all time high TTM CFO for ENDRA Life Sciences?
  • What is ENDRA Life Sciences TTM CFO year-on-year change?

What is ENDRA Life Sciences annual cash flow from operations?

The current annual CFO of NDRA is -$9.55 M

What is the all time high annual CFO for ENDRA Life Sciences?

ENDRA Life Sciences all-time high annual cash flow from operations is -$842.70 K

What is ENDRA Life Sciences annual CFO year-on-year change?

Over the past year, NDRA annual cash flow from operations has changed by +$3.22 M (+25.22%)

What is ENDRA Life Sciences quarterly cash flow from operations?

The current quarterly CFO of NDRA is -$1.66 M

What is the all time high quarterly CFO for ENDRA Life Sciences?

ENDRA Life Sciences all-time high quarterly cash flow from operations is $0.00

What is ENDRA Life Sciences quarterly CFO year-on-year change?

Over the past year, NDRA quarterly cash flow from operations has changed by +$941.60 K (+36.23%)

What is ENDRA Life Sciences TTM cash flow from operations?

The current TTM CFO of NDRA is -$8.06 M

What is the all time high TTM CFO for ENDRA Life Sciences?

ENDRA Life Sciences all-time high TTM cash flow from operations is -$53.80 K

What is ENDRA Life Sciences TTM CFO year-on-year change?

Over the past year, NDRA TTM cash flow from operations has changed by +$2.40 M (+22.97%)